NR2C2 and renal cell carcinoma: Importantly, interruption approaches with MTT assay also revealed that increasing TR4 expression could promote RCC sunitinib resistance (Fig. 1d, e), while suppressing TR4 via adding TR4-shRNA resulted in a decrease in the sunitinib resistance in OSRC-2 and SW839 cells (Fig. 1f, g).